Tel Mond, Israel

Moshe Weinstein


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Moshe Weinstein

Introduction

Moshe Weinstein is a notable inventor based in Tel Mond, Israel. He has made significant contributions to the field of medical treatments, particularly in the management of pain associated with articular disorders. His innovative approach has led to the development of a unique therapeutic composition that aims to improve patient outcomes.

Latest Patents

Moshe Weinstein holds 1 patent for his invention titled "Long-acting liposomal composition for treatment of pain in articular disorders." This patent describes a method of treating subjects with articular disorders through the administration of a long-acting liposomal composition. The preferred formulation includes phosphatidylcholine as the sole active ingredient, which can be derived from various sources. The method involves a single intra-articular injection administered once every 4 to 12 months, providing pain relief and reducing irritation in the affected joints.

Career Highlights

Weinstein is associated with Moebius Medical Ltd., where he continues to work on innovative solutions in the medical field. His dedication to research and development has positioned him as a key figure in advancing treatment options for patients suffering from joint-related issues.

Collaborations

One of his notable collaborators is Ron Pinkus, with whom he has worked closely to further enhance the effectiveness of their medical innovations.

Conclusion

Moshe Weinstein's contributions to the field of pain management through his patented liposomal composition exemplify the impact of innovative thinking in medicine. His work continues to pave the way for improved therapeutic options for patients with articular disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…